Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement

Leukemia Research

Volumn 31, Issue 10, 2007, Pages 1437-1440

  Suminoe, Aiko ^a   Matsuzaki, Akinobu ^a,b   Hattori, Hiroyoshi ^a   Koga, Yuhki ^a   Ishii, Eiichi ^c   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Dissemination; Leukemia; Metalloproteinase; MMP; Organ involvement; TIMP

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

FEMALE; GENE EXPRESSION; HUMANS; INFANT; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 34547678257     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.01.015     Document Type: Article

References (8)

1. Deryugina E.I., and Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metast Rev 25 (2006) 9-34
2. Klein G., Vellenga E., Fraaije M.W., Kamps W.A., and de Bont E.S. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 50 (2004) 87-100
3. Lambert E., Dasse E., Haye B., and Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49 (2004) 187-198
4. Hendrix M.J., Seftor E.A., Grogan T.M., Seftor R.E., Hersh E.M., Boyse E.A., et al. Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice. Mol Cell Probes 6 (1992) 59-65
5. Kuittinen O., Savolainen E.R., Koistinen P., Mottonen M., and Turpeenniemi-Hujanen T. MMP-2 and MMP-9 expression in adult and childhood acute lymphatic leukemia (ALL). Leuk Res 25 (2001) 125-131
6. Lin L.I., Lin D.T., Chang C.J., Lee C.Y., Tang J.L., and Tien H.F. Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia. Br J Haematol 117 (2002) 835-841
7. Isoyama K., Eguchi M., Hibi S., Kinukawa N., Ohkawa H., Kawasaki H., et al. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96). Br J Haematol 118 (2002) 999-1010
8. Aref S., El-Sherbiny M., Mabed M., Meness A., and El-Refaei M. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion. Hematology 8 (2003) 385-391